InvestorsHub Logo
Followers 51
Posts 3078
Boards Moderated 0
Alias Born 05/11/2016

Re: None

Monday, 02/13/2017 1:52:19 PM

Monday, February 13, 2017 1:52:19 PM

Post# of 8109
recently completed a pivot away from developing agricultural technologies and toward medical marijuana cultivation and cannabinoid biopharmaceutical development. By doing so, the company aims to generate near-term revenue to help offset the cost of developing cannabinoid-based biopharmaceuticals with blockbuster potential. Investors may want to take a closer look at the stock given the new focus.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent GBLX News